Insmed INSM Ratios & Valuation
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| Profitability | |||||
| Gross margin | 308.5%-0.9pp | 309.3%-4.5pp | 313.9%+5.8pp | 308.1%+4.8pp | |
| Operating margin | -974.4%-36.5pp | -937.8%-15.9pp | -921.9%-207pp | -715%+58.8pp | |
| Net margin | -1,001.1%-16.9pp | -984.3%-10.4pp | -973.8%-193pp | -781%+104pp | |
| Returns | |||||
| Return on invested capital | -814.9%+233pp | -1,047.6%-315pp | -732.7%-189pp | -544.1%+128pp | |
| Efficiency | |||||
| Asset turnover | 0.9×+0.1× | 0.9×0.0× | 0.9×+0.1× | 0.8×0.0× | |
| Liquidity | |||||
| Current ratio | 21×+4.7× | 16.3×-3.7× | 20×-3.3× | 23.3×-8.0× | |
| Leverage | |||||
| Debt-to-equity | 13.4×— | —— | —— | —— | |
| Per Share | |||||
| Book value per share | $15.33+833% | $1.64+128% | -$5.85-417% | $1.84-87.5% | |
| Valuation | |||||
| Market capitalization | $101.48B+170% | $37.52B+179% | $13.46B+25.9% | $10.69B-21.1% | |
| Price / sales | 216.1×+106× | 109.6×+61.8× | 47.9×+0.6× | 47.3×-30.4× | |
| Price / book | 237.8×— | —— | —— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Insmed's profit margins?
- Insmed (INSM) runs a 81.8% gross margin and a -140.6% operating margin, with a -144.4% net margin.
- Where do Insmed's ratios come from?
- Every ratio is computed from Insmed's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
